...
首页> 外文期刊>Medicine. >Effect of Hypertension on Outcomes of High-Risk Patients After BCG-Treated Bladder Cancer A Single-Institution Long Follow-Up Cohort Study
【24h】

Effect of Hypertension on Outcomes of High-Risk Patients After BCG-Treated Bladder Cancer A Single-Institution Long Follow-Up Cohort Study

机译:高血压对BCG治疗后膀胱癌后高危患者结果的影响单一机构长期随访队列研究

获取原文
获取原文并翻译 | 示例

摘要

Immunotherapy with Bacillus Calmette Guerin (BCG) is the most efficacious treatment for high-risk bladder cancer (BC) (Ta/T1 or carcinoma in situ) to reduce the risk of recurrence. Our aim was to evaluate whether hypertension and diabetes influence the outcome of patients with noninvasive BC treated with BCG instillations.
机译:用芽孢杆菌(Bacillus Guerin)(BCG)的免疫疗法是对高危膀胱癌(BC)(TA / T1或癌原位的)最有效的治疗方法,以降低复发的风险。 我们的目标是评估高血压和糖尿病是否影响了使用BCG滴注治疗的非侵入性BC患者的结果。

著录项

  • 来源
    《Medicine. 》 |2015年第9期| 共5页
  • 作者单位

    Azienda Osped Padova Dept Surg Oncol &

    Gastroenterol Sci Urol Padua Italy;

    Azienda Osped Padova Dept Surg Oncol &

    Gastroenterol Sci Urol Padua Italy;

    Azienda Osped Padova Dept Surg Oncol &

    Gastroenterol Sci Urol Padua Italy;

    Azienda Osped Padova Dept Med DIMED Metab Dis &

    Cardiovasc Risk Unit Padua Italy;

    Azienda Osped Padova Dept Pathol Padua Italy;

    Azienda Osped Padova Dept Surg Oncol &

    Gastroenterol Sci Urol Padua Italy;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医药、卫生 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号